- Record: found
- Abstract: not found
- Article: not found
INFORM2 exploratory multinational phase I/II combination study of nivolumab and entinostat in children and adolescents with refractory high‐risk malignancies: INFORM2 NivEnt
CM van Tilburg, R. Witt, KW Pajtler, Cornelis van Tilburg, Ruth Witt, Kristian Pajtler, Plass Christoph, Isabel Poschke, Michael Platten, Inga Harting, Oliver Sedlaczek, Angelika Freitag, David Meyrath, Lenka Taylor, Gnana Balasubramanian, Natalie Jäger, Elke Pfaff, Barbara C Worst, Till Milde, Stefan Pfister, David T. Jones, Annette Kopp-Schneider, Olaf Witt
2019
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.